II. Indications

  1. Extremely limited use in clinical practice
  2. May be indicated if spondylitis strongly suspected

III. Methods of Testing

  1. Antibody binding to patient's cells
  2. Mixed Lymphocyte responses against specific targets
  3. Hybridization to DNA probes

V. Conditions associated with HLA-B27 (with Incidence)

  1. Ankylosing Spondylitis: 95%
  2. Reiter's Syndrome: 80%
  3. Spondylitis with Psoriasis: 70%
  4. Spondylitis with Inflammatory Bowel Disease: 50%
  5. Incidence in general population without disease: 6-8%

VI. References

  1. Gregersen in Ruddy (2001) Kelly's Rheumatology, p. 101
  2. Lane (2002) Am Fam Physician 65(6):1073-80

Images: Related links to external sites (from Bing)

Related Studies (from Trip Database) Open in New Window